 In Russia, picamilon is sold as a prescription drug.The rights to the drug belong to the Russian pharmaceutical company NPK ECHO ("НПК ЭХО").It is not approved for sale in the United States and has been deemed an adulterating agent in dietary supplements, with five American companies required to remove their picamilon products from the market in November, 2015.